Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bumetanide: a new loop diuretic (Bumex, Roche Laboratories).

C E Halstenson, G R Matzke

    Drug Intelligence & Clinical Pharmacy
    |November 1, 1983
    PubMed
    Summary

    Bumetanide, a potent diuretic, effectively manages edema in heart failure, liver cirrhosis, and kidney insufficiency. While similar to furosemide, its higher potency and risk of electrolyte imbalance warrant careful consideration.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Two randomized, double-blind, placebo-controlled, dose-escalation phase 1 studies evaluating BTH1677, a 1, 3-1,6 beta glucan pathogen associated molecular pattern, in healthy volunteer subjects.

    Investigational new drugs·2016
    Same author

    Characterization of tubular functional capacity in humans using para-aminohippurate and famotidine.

    Kidney international·2001
    Same author

    Effect of ceftazidime on systemic cytokine concentrations in rats.

    Antimicrobial agents and chemotherapy·2000
    Same author

    Pharmacokinetics and blood pressure response of losartan in end-stage renal disease.

    Clinical pharmacokinetics·2000
    Same author

    Determinants of ceftriaxone clearance by continuous venovenous hemofiltration and hemodialysis.

    Pharmacotherapy·2000
    Same author

    Nephrology pharmaceutical care preceptorship: a programmatic and clinical outcomes assessment.

    The Annals of pharmacotherapy·2000

    Area of Science:

    • Pharmacology and Nephrology

    Background:

    • Bumetanide is a potent loop diuretic.
    • It acts on the thick ascending limb of the loop of Henle to inhibit sodium transport.
    • Structurally and pharmacologically similar to furosemide, it is approximately 40 times more potent.

    Purpose of the Study:

    • To evaluate the efficacy and safety of bumetanide in managing edema.
    • To compare bumetanide's pharmacokinetic and adverse reaction profiles with furosemide.
    • To identify potential indications and limitations for bumetanide use.

    Main Methods:

    • Pharmacokinetic analysis after oral administration.
    • Clinical efficacy assessment in patients with edema.
    • Adverse event monitoring and comparison with furosemide.

    Main Results:

    • Bumetanide is rapidly absorbed, reaching peak serum concentrations in approximately 30 minutes.
    • It demonstrates efficacy in treating edema associated with congestive heart failure, hepatic cirrhosis, and renal insufficiency.
    • Adverse reactions are similar to furosemide, with a higher incidence of hypochloremia and hypokalemia; furosemide has a higher incidence of hyperglycemia and ototoxicity.

    Conclusions:

    • Bumetanide is a potent diuretic with established efficacy in edema management.
    • Its primary indication may be in patients at risk of ototoxicity.
    • Cost-effectiveness suggests a secondary role for bumetanide in most clinical settings for fluid retention.

    Related Experiment Videos